79 related articles for article (PubMed ID: 30182384)
21. A sequence-based method to predict the impact of regulatory variants using random forest.
Liu Q; Gan M; Jiang R
BMC Syst Biol; 2017 Mar; 11(Suppl 2):7. PubMed ID: 28361702
[TBL] [Abstract][Full Text] [Related]
22. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
Brewster BL; Rossiello F; French JD; Edwards SL; Wong M; Wronski A; Whiley P; Waddell N; Chen X; Bove B; ; Hopper JL; John EM; Andrulis I; Daly M; Volorio S; Bernard L; Peissel B; Manoukian S; Barile M; Pizzamiglio S; Verderio P; Spurdle AB; Radice P; Godwin AK; Southey MC; Brown MA; Peterlongo P
Hum Mutat; 2012 Dec; 33(12):1665-75. PubMed ID: 22753153
[TBL] [Abstract][Full Text] [Related]
23. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
24. SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
Han W; Kim KY; Yang SJ; Noh DY; Kang D; Kwack K
Cancer; 2012 Feb; 118(3):594-602. PubMed ID: 21751184
[TBL] [Abstract][Full Text] [Related]
25. Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk.
Popanda O; Seibold P; Nikolov I; Oakes CC; Burwinkel B; Hausmann S; Flesch-Janys D; Plass C; Chang-Claude J; Schmezer P
Int J Cancer; 2013 Jan; 132(1):55-62. PubMed ID: 22684821
[TBL] [Abstract][Full Text] [Related]
26. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
27. ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
Renault AL; Lesueur F; Coulombe Y; Gobeil S; Soucy P; Hamdi Y; Desjardins S; Le Calvez-Kelm F; Vallée M; Voegele C; ; Hopper JL; Andrulis IL; Southey MC; John EM; Masson JY; Tavtigian SV; Simard J
PLoS One; 2016; 11(6):e0156820. PubMed ID: 27270457
[TBL] [Abstract][Full Text] [Related]
28. An integrative functional genomics framework for effective identification of novel regulatory variants in genome-phenome studies.
Zhao J; Cheng F; Jia P; Cox N; Denny JC; Zhao Z
Genome Med; 2018 Jan; 10(1):7. PubMed ID: 29378629
[TBL] [Abstract][Full Text] [Related]
29. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
Bayram S; Sümbül AT; Dadaş E
Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
[TBL] [Abstract][Full Text] [Related]
30. Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population.
Morales S; Gulppi F; Gonzalez-Hormazabal P; Fernandez-Ramires R; Bravo T; Reyes JM; Gomez F; Waugh E; Jara L
BMC Genet; 2016 Jul; 17(1):109. PubMed ID: 27421647
[TBL] [Abstract][Full Text] [Related]
31. Germline allelic expression of genes at 17q22 locus associates with risk of breast cancer.
Esteves F; Xavier JM; Ford AM; Rocha C; Pharoah PDP; Caldas C; Chin SF; Maia AT
Eur J Cancer; 2022 Sep; 172():146-157. PubMed ID: 35772352
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer associated germline structural variants harboring small noncoding RNAs impact post-transcriptional gene regulation.
Kumaran M; Krishnan P; Cass CE; Hubaux R; Lam W; Yasui Y; Damaraju S
Sci Rep; 2018 May; 8(1):7529. PubMed ID: 29760470
[TBL] [Abstract][Full Text] [Related]
33. Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.
Manjunath M; Yan J; Youn Y; Drucker KL; Kollmeyer TM; McKinney AM; Zazubovich V; Zhang Y; Costello JF; Eckel-Passow J; Selvin PR; Jenkins RB; Song JS
Neuro Oncol; 2021 Apr; 23(4):638-649. PubMed ID: 33130899
[TBL] [Abstract][Full Text] [Related]
34. A Genome-Wide Association Study to Identify Potential Germline Copy Number Variants for Sporadic Breast Cancer Susceptibility.
Sapkota Y; Narasimhan A; Kumaran M; Sehrawat BS; Damaraju S
Cytogenet Genome Res; 2016; 149(3):156-164. PubMed ID: 27668787
[TBL] [Abstract][Full Text] [Related]
35. Computational Analysis of Breast Cancer GWAS Loci Identifies the Putative Deleterious Effect of STXBP4 and ZNF404 Gene Variants.
Masoodi TA; Banaganapalli B; Vaidyanathan V; Talluri VR; Shaik NA
J Cell Biochem; 2017 Dec; 118(12):4296-4307. PubMed ID: 28422318
[TBL] [Abstract][Full Text] [Related]
36. Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control.
Hamdi Y; Leclerc M; Dumont M; Dubois S; Tranchant M; Reimnitz G; Soucy P; Cassart P; Ouimet M; Sinnett D; Chaieb MLL; Simard J
Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30823486
[TBL] [Abstract][Full Text] [Related]
37. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
[TBL] [Abstract][Full Text] [Related]
38. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
39. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
40. Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls.
Behravan H; Hartikainen JM; Tengström M; Pylkäs K; Winqvist R; Kosma VM; Mannermaa A
Sci Rep; 2018 Sep; 8(1):13149. PubMed ID: 30177847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
